💊 Endoglycosidase NDCs, Ingredients & Package Codes
NDC package records in the Endoglycosidase class — ingredients, strengths, dosage forms, labelers, package codes and pricing data where available, with links to each individual NDC page. (Established Pharmacologic Class is the FDA’s grouping of “what kind of drug this is.”)
30
Package NDCs
42
Products
42
Active listings
14
Ingredients
10
Labelers
24
Strengths
4
Dosage forms
1
With NADAC pricing
Inside this class
Top ingredients by product count
Top labelers
Dosage forms
Browse records
💉
AMPHADASE hyaluronidase 150 [USP'U]/mL INJECTION
Rx only
Brand
On market
Non-controlled
—
💉
Darzalex Faspro daratumumab and hyaluronidase-fihj (human recombinant) 1800 mg/15mL; 30000 U/15mL INJECTION
Rx only
Brand
On market
Non-controlled
—
💉
Darzalex Faspro daratumumab and hyaluronidase-fihj (human recombinant) 1800 mg/15mL; 30000 U/15mL INJECTION
Rx only
Brand
On market
Non-controlled
—
💧
—
💉
Herceptin Hylecta Trastuzumab and hyaluronidase-oysk 600 mg/5mL; 10000 U/5mL INJECTION, SOLUTION
Rx only
Brand
Discontinued
Non-controlled
—
💉
HYALURONIDASE 150 [USP'U]/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
HYLENEX Recombinant Hyaluronidase 150 [USP'U]/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
$53.705/unit · NADAC
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
Ocrevus Zunovo ocrelizumab and hyaluronidase 920 mg/23mL; 23000 U/23mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
Ocrevus Zunovo ocrelizumab and hyaluronidase 920 mg/23mL; 23000 U/23mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
OPDIVO QVANTIG nivolumab and hyaluronidase-nvhy 120 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
OPDIVO QVANTIG nivolumab and hyaluronidase-nvhy 120 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
OPDIVO QVANTIG nivolumab and hyaluronidase-nvhy 120 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
OPDIVO QVANTIG nivolumab and hyaluronidase-nvhy 120 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
🧴
—
🧴
—
💉
Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf 1200 mg/15mL; 600 mg/15mL; 30000 U/15mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf 600 mg/10mL; 600 mg/10mL; 20000 U/10mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
Rituxan Hycela rituximab and hyaluronidase 120 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
Rituxan Hycela rituximab and hyaluronidase 120 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 2400 mg/15mL; 30000 mg/15mL INJECTION
Rx only
Brand
On market
Non-controlled
—
Where does this data come from?
Class membership is the FDA Established Pharmacologic Class (EPC) from the openFDA NDC Directory; ingredient, labeler, strength and form counts are aggregated from the same source, with NADAC pricing from CMS.
Browse other drug classes
Nonsteroidal Anti-inflammatory Drug 4,136
Corticosteroid 3,119
Central Nervous System Stimulant 2,655
Histamine-1 Receptor Antagonist 2,636
Antiarrhythmic 2,394
Amide Local Anesthetic 2,285
Sigma-1 Agonist 2,226
beta-Adrenergic Blocker 1,882
Uncompetitive N-methyl-D-aspartate Receptor Antagonist 1,755
Atypical Antipsychotic 1,677
Opioid Agonist 1,654
Expectorant 1,584
Calculi Dissolution Agent 1,570
HMG-CoA Reductase Inhibitor 1,477
Angiotensin 2 Receptor Blocker 1,457
Copper Absorption Inhibitor 1,413
Blood Coagulation Factor 1,314
Serotonin Reuptake Inhibitor 1,269
Non-Standardized Pollen Allergenic Extract 1,160
Non-Standardized Food Allergenic Extract 1,158
Proton Pump Inhibitor 1,124
Osmotic Laxative 1,112
Anti-epileptic Agent 1,091
Calcium Channel Blocker 1,085
alpha-1 Adrenergic Agonist 1,062
Azole Antifungal 1,025
Penicillin-class Antibacterial 1,023
Angiotensin Converting Enzyme Inhibitor 999
Non-Standardized Plant Allergenic Extract 994
Benzodiazepine 969
Cholinergic Nicotinic Agonist 925
Phosphate Binder 899
alpha-Adrenergic Agonist 894
Thiazide Diuretic 885
Antihistamine 864
Mood Stabilizer 817